Gene Expression Data
Assay Details
Assay
|
Reference:
|
J:72911
Murdoch JN, et al., Severe neural tube defects in the loop-tail mouse result from mutation of Lpp1, a novel gene involved in floor plate specification. Hum Mol Genet. 2001 Oct 15;10(22):2593-601
|
Assay type:
|
RNA in situ
|
MGI Accession ID:
|
MGI:6451127
|
Gene symbol:
|
Vangl2
|
Gene name:
|
VANGL planar cell polarity 2
|
Probe:
|
Lpp1 cDNA1
|
Probe preparation:
|
Antisense RNA
|
|
Results
|
Specimen
3B:
embryonic day 8.5; Vangl2Lp/Vangl2 +
(more )
Note: 7-8 somite stage embryo.
Specimen
3B:
(close )
Genetic Background:
|
LPT/LeJ
|
Mutant Allele(s):
|
Vangl2Lp/Vangl2+
|
Age:
|
embryonic day 8.5
|
Sex:
|
Not Specified
|
Type:
|
whole mount
|
Fixation:
|
4% Paraformaldehyde
|
Note:
|
7-8 somite stage embryo.
|
Structure |
Level |
Pattern |
Image |
Note |
TS13: future hindbrain |
Present |
Regionally restricted |
3B
|
Expression is as a midline stripe extending from the midbrain to the upper spinal region.
|
TS13: future midbrain |
Present |
Regionally restricted |
3B
|
Expression is as a midline stripe extending from the midbrain to the upper spinal region.
|
TS13: future spinal cord |
Present |
Regionally restricted |
3B
|
Expression extends to the site of neural tube closure and declines in a rostro-caudal direction.
|
TS13: future prosencephalon |
Present |
Regionally restricted |
3B
|
Expression extends to the occipital region.
|
Specimen
3C:
embryonic day 8.5; Vangl2Lp/Vangl2 +
(more )
Note: 7-8 somite stage embryo.
Specimen
3C:
(close )
Genetic Background:
|
LPT/LeJ
|
Mutant Allele(s):
|
Vangl2Lp/Vangl2+
|
Age:
|
embryonic day 8.5
|
Sex:
|
Not Specified
|
Type:
|
whole mount
|
Fixation:
|
4% Paraformaldehyde
|
Note:
|
7-8 somite stage embryo.
|
Structure |
Level |
Pattern |
Image |
Note |
TS13: future hindbrain |
Present |
Regionally restricted |
3C
|
Expression is as a midline stripe extending from the midbrain to the upper spinal region.
|
TS13: future midbrain |
Present |
Regionally restricted |
3C
|
Expression is as a midline stripe extending from the midbrain to the upper spinal region.
|
TS13: future spinal cord |
Present |
Regionally restricted |
3C
|
Expression extends to the site of neural tube closure and declines in a rostro-caudal direction.
|
TS13: future prosencephalon |
Present |
Regionally restricted |
3C
|
Expression extends to the occipital region.
|
Specimen
3D:
embryonic day 8.5; Vangl2Lp/ Vangl2Lp
(more )
Note: 7-8 somite stage embryo.
Specimen
3D:
(close )
Genetic Background:
|
LPT/LeJ
|
Mutant Allele(s):
|
Vangl2Lp/Vangl2Lp
|
Age:
|
embryonic day 8.5
|
Sex:
|
Not Specified
|
Type:
|
whole mount
|
Fixation:
|
4% Paraformaldehyde
|
Note:
|
7-8 somite stage embryo.
|
Structure |
Level |
Pattern |
Image |
Note |
TS13: future hindbrain |
Present |
Regionally restricted |
3D
|
Expression is as a midline stripe extending from the midbrain to the upper spinal region.
|
TS13: future midbrain |
Present |
Regionally restricted |
3D
|
Expression is as a midline stripe extending from the midbrain to the upper spinal region.
|
TS13: future spinal cord |
Present |
Regionally restricted |
3D
|
Expression extends to the site of neural tube closure and declines in a rostro-caudal direction.
|
TS13: future prosencephalon |
Present |
Regionally restricted |
3D
|
Expression extends to the occipital region.
|
Specimen
3E:
embryonic day 8.5; Vangl2Lp/ Vangl2Lp
(more )
Note: 7-8 somite stage embryo.
Specimen
3E:
(close )
Genetic Background:
|
LPT/LeJ
|
Mutant Allele(s):
|
Vangl2Lp/Vangl2Lp
|
Age:
|
embryonic day 8.5
|
Sex:
|
Not Specified
|
Type:
|
whole mount
|
Fixation:
|
4% Paraformaldehyde
|
Note:
|
7-8 somite stage embryo.
|
Structure |
Level |
Pattern |
Image |
Note |
TS13: future hindbrain |
Present |
Regionally restricted |
3E
|
Expression is as a midline stripe extending from the midbrain to the upper spinal region.
|
TS13: future midbrain |
Present |
Regionally restricted |
3E
|
Expression is as a midline stripe extending from the midbrain to the upper spinal region.
|
TS13: future spinal cord |
Present |
Regionally restricted |
3E
|
Expression extends to the site of neural tube closure and declines in a rostro-caudal direction.
|
TS13: future prosencephalon |
Present |
Regionally restricted |
3E
|
Expression extends to the occipital region.
|
Specimen
3F:
embryonic day 9.5
(more )
Specimen
3F:
(close )
Genetic Background:
|
Not Specified
|
Age:
|
embryonic day 9.5
|
Sex:
|
Not Specified
|
Type:
|
whole mount
|
Fixation:
|
4% Paraformaldehyde
|
Structure |
Level |
Pattern |
Image |
Note |
TS15: future hindbrain |
Present |
Regionally restricted |
3F
|
Expression is as a midline stripe extending from the midbrain into most of the spine with the intensity declining in a rostro-caudal direction.
|
TS15: future midbrain |
Present |
Regionally restricted |
3F
|
Expression is as a midline stripe extending from the midbrain into most of the spine with the intensity declining in a rostro-caudal direction.
|
TS15: future spinal cord |
Present |
Regionally restricted |
3F
|
Expression is as a midline stripe extending from the midbrain into most of the spine with the intensity declining in a rostro-caudal direction.
|
TS15: future forebrain |
Present |
|
3F
|
|
Specimen
3G:
(close )
Genetic Background:
|
LPT/LeJ
|
Mutant Allele(s):
|
Vangl2Lp/Vangl2Lp
|
Age:
|
embryonic day 9.5
|
Sex:
|
Not Specified
|
Type:
|
whole mount
|
Fixation:
|
4% Paraformaldehyde
|
Structure |
Level |
Pattern |
Image |
Note |
TS15: future hindbrain |
Present |
Regionally restricted |
3G
|
Expression is as a midline stripe extending from the midbrain into most of the spine with the intensity declining in a rostro-caudal direction.
|
TS15: future midbrain |
Present |
Regionally restricted |
3G
|
Expression is as a midline stripe extending from the midbrain into most of the spine with the intensity declining in a rostro-caudal direction.
|
TS15: future spinal cord |
Present |
Regionally restricted |
3G
|
Expression is as a midline stripe extending from the midbrain into most of the spine with the intensity declining in a rostro-caudal direction.
|
TS15: future forebrain |
Present |
|
3G
|
|
Specimen
3H:
embryonic day 8.5; Vangl2Lp/Vangl2 +
(more )
Note: 7-8 somite stage embryo.
Specimen
3H:
(close )
Genetic Background:
|
LPT/LeJ
|
Mutant Allele(s):
|
Vangl2Lp/Vangl2+
|
Age:
|
embryonic day 8.5
|
Sex:
|
Not Specified
|
Type:
|
section from whole mount
|
Fixation:
|
4% Paraformaldehyde
|
Note:
|
7-8 somite stage embryo.
|
Specimen
3I:
embryonic day 8.5; Vangl2Lp/ Vangl2Lp
(more )
Note: 7-8 somite stage embryo.
Specimen
3I:
(close )
Genetic Background:
|
LPT/LeJ
|
Mutant Allele(s):
|
Vangl2Lp/Vangl2Lp
|
Age:
|
embryonic day 8.5
|
Sex:
|
Not Specified
|
Type:
|
section from whole mount
|
Fixation:
|
4% Paraformaldehyde
|
Note:
|
7-8 somite stage embryo.
|
Specimen
3J:
embryonic day 9.5
(more )
Specimen
3J:
(close )
Genetic Background:
|
Not Specified
|
Age:
|
embryonic day 9.5
|
Sex:
|
Not Specified
|
Type:
|
section from whole mount
|
Fixation:
|
4% Paraformaldehyde
|
Specimen
3K:
(close )
Genetic Background:
|
LPT/LeJ
|
Mutant Allele(s):
|
Vangl2Lp/Vangl2Lp
|
Age:
|
embryonic day 9.5
|
Sex:
|
Not Specified
|
Type:
|
section from whole mount
|
Fixation:
|
4% Paraformaldehyde
|
Specimen
3L:
embryonic day 9.5
(more )
Specimen
3L:
(close )
Genetic Background:
|
Not Specified
|
Age:
|
embryonic day 9.5
|
Sex:
|
Not Specified
|
Type:
|
whole mount
|
Fixation:
|
4% Paraformaldehyde
|
Structure |
Level |
Pattern |
Image |
Note |
TS15: future spinal cord |
Present |
Regionally restricted |
3L
|
Expression is as a midline stripe extending into most of the spine with the intensity declining in a rostro-caudal direction.
|
Specimen
3M:
(close )
Genetic Background:
|
LPT/LeJ
|
Mutant Allele(s):
|
Vangl2Lp/Vangl2Lp
|
Age:
|
embryonic day 9.5
|
Sex:
|
Not Specified
|
Type:
|
whole mount
|
Fixation:
|
4% Paraformaldehyde
|
Structure |
Level |
Pattern |
Image |
Note |
TS15: future spinal cord |
Present |
Regionally restricted |
3M
|
Expression is as a midline stripe extending into most of the spine with the intensity declining in a rostro-caudal direction.
|
Specimen
3N:
embryonic day 16.5
(more )
Specimen
3N:
(close )
Genetic Background:
|
Not Specified
|
Age:
|
embryonic day 16.5
|
Sex:
|
Female
|
Type:
|
section
|
Fixation:
|
4% Paraformaldehyde
|
Embedding:
|
Paraffin
|
Specimen
3O:
embryonic day 15.5
(more )
Specimen
3O:
(close )
Genetic Background:
|
Not Specified
|
Age:
|
embryonic day 15.5
|
Sex:
|
Not Specified
|
Type:
|
section
|
Fixation:
|
4% Paraformaldehyde
|
Embedding:
|
Paraffin
|
Structure |
Level |
Pattern |
Image |
Note |
TS23: eyelid epithelium |
Present |
Regionally restricted |
3O
|
Expression is in the outer eyelid epithelium and at the site of eyelid fusion.
|
Specimen
3P:
embryonic day 12.5
(more )
Specimen
3P:
(close )
Genetic Background:
|
Not Specified
|
Age:
|
embryonic day 12.5
|
Sex:
|
Not Specified
|
Type:
|
section
|
Fixation:
|
4% Paraformaldehyde
|
Embedding:
|
Paraffin
|
Structure |
Level |
Pattern |
Image |
Note |
TS20: outflow tract |
Strong |
Regionally restricted |
3P
|
Expression is in the right ventricular outflow tract.
|
Specimen
3Q:
embryonic day 14.5
(more )
Specimen
3Q:
(close )
Genetic Background:
|
Not Specified
|
Age:
|
embryonic day 14.5
|
Sex:
|
Not Specified
|
Type:
|
section
|
Fixation:
|
4% Paraformaldehyde
|
Embedding:
|
Paraffin
|
Specimen
4A:
embryonic day 9.5
(more )
Specimen
4A:
(close )
Genetic Background:
|
Not Specified
|
Age:
|
embryonic day 9.5
|
Sex:
|
Not Specified
|
Type:
|
section
|
Fixation:
|
4% Paraformaldehyde
|
Embedding:
|
Paraffin
|
Specimen
4C:
embryonic day 10.5
(more )
Specimen
4C:
(close )
Genetic Background:
|
Not Specified
|
Age:
|
embryonic day 10.5
|
Sex:
|
Not Specified
|
Type:
|
section
|
Fixation:
|
4% Paraformaldehyde
|
Embedding:
|
Paraffin
|
Specimen
4E:
(close )
Genetic Background:
|
involves: 129S1/Sv * 129X1/SvJ
|
Mutant Allele(s):
|
Shhtm1Chg/Shhtm1Chg
|
Age:
|
embryonic day 9.5
|
Sex:
|
Not Specified
|
Type:
|
whole mount
|
Fixation:
|
4% Paraformaldehyde
|
Specimen
4F:
(close )
Genetic Background:
|
involves: 129S1/Sv * 129X1/SvJ
|
Mutant Allele(s):
|
Shhtm1Chg/Shhtm1Chg
|
Age:
|
embryonic day 9.5
|
Sex:
|
Not Specified
|
Type:
|
section from whole mount
|
Fixation:
|
4% Paraformaldehyde
|
|